MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Pre-surgical correlates of QoL (PDQ-39) in a DBS eligible PD population

    J. Jimenez-Shahed, A. Berg, J. Kirk, M. York, J. Schwalb, M. Siddiqui, J. Mcinerney (New York, USA)

    Objective: To investigate the pre-surgical correlates of quality of life (QoL) in patients with Parkinson's disease (PD) eligible for deep brain stimulation (DBS). Background: Optimizing…
  • 2023 International Congress

    Striatal neurodegeneration in female carriers of the TAF1 Mutation Causing X-linked Dystonia-Parkinsonism

    H. Hanssen, J. Dy, J. Tantianpact, M. Heldmann, H. Manalo, C. Klein, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Lübeck, Germany)

    Objective: To determine whether structural brain changes are present in female carriers (MC) of the TAF1 pathogenic change causing X-linked dystonia-parkinsonism (XDP). Background: XDP is an X-linked…
  • 2023 International Congress

    Serum levels of IL-1β and interleukin 6 in Parkinson’s disease

    S. Fezai, M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj (Tunis, Tunisia)

    Objective: We aim to assess IL-1 β and IL-6 serum levels in patients with PD and in controls and to explore their associations with clinical…
  • 2023 International Congress

    Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

    R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)

    Objective: To describe a rare case of NUS1 gene mutation related progressive epilepsy myoclonus ataxia syndrome. Background: Pathogenic variants of NUS1 gene have been associated…
  • 2023 International Congress

    A randomized, phase 2a, double-blind, placebo-controlled clinical trial with NE3107 adjunctive to carbidopa/levodopa in patients with Parkinson’s disease

    J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

    Objective: To evaluate the motor effects of NE3107 treatment in patients with levodopa-treated Parkinson’s disease (PD) experiencing motor fluctuations. Background: NE3107 is an oral, blood-brain…
  • 2023 International Congress

    Hypoxic brain injury: a rare cause of chorea and dystonia

    S. Casanova, M. Rocha, A. Rocha, M. Magalhães, H. Costa (Vila Nova Gaia, Portugal)

    Objective: To present a rare case of chorea and dystonia development in a young patient following cardiac arrest. Background: An hypoxic brain injury can potentially…
  • 2023 International Congress

    FGF14 repeat expansions: Case series of adult-onset cerebellar ataxia patients from Serbia

    A. Milovanović, NT. Dragašević Mišković, M. Borsche, A. Westenberger, N. Brueggemann, M. Svetel, I. Petrović, VS. Kostić, K. Lohmann (Belgrade, Serbia)

    Objective: The aim of this study was to investigate the presence of pathogenic repeat expansion in the FGF14 gene in patients with adult-onset cerebellar ataxia…
  • 2023 International Congress

    The predictive potential of circular walking in prodromal Parkinson’s disease

    ME. Micó-Amigo, I. Kingma, S. Heinzel, S. Solbrig, MA. Hobert, M. Elshehabi, K. Brockmann, FG. Metzger, R. van Lummel, D. Berg, W. Maetzler, JH. van Dieen (Edinburgh, United Kingdom)

    Objective: This study aims to provide quantitative markers of prodromal motor symptoms of idiopathic Parkinson’s disease (PD) from circular walking assessment with a single body-fixed-sensor.…
  • 2023 International Congress

    Machine learning diagnosis of parkinsonian syndromes: network approach with two different sites

    M. Perovnik, T. Rus, A. Vo, N. Nguyen, P. Tomše, J. Jamšek, C. Tang, M. Trošt, D. Eidelberg (Ljubljana, Slovenia)

    Objective: To test an automated differential diagnostic algorithm for parkinsonian syndromes based on machine learning and FDG-PET scans using subject scores for sets of validated…
  • 2023 International Congress

    A minimal clinically important difference for UHDRS® Total Maximal Chorea score as a measure of chorea severity in Huntington disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To establish a minimal clinically important difference (MCID) for the Unified Huntington Disease Rating Scale (UHDRS®) Total Maximal Chorea (TMC) score as a measure…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley